BrainCo’s brain-computer interface (BCI) garnered significant attention at the HSBC summit with a demonstration of a bionic hand controlled by thought. This was reported by SCMP.
The technology non-invasively reads neural signals through the skin and converts them into commands for devices. This feature also aids patients in managing symptoms of certain diseases.
“For severe brain diseases like Parkinson’s or for blind individuals, surgical intervention may be required. However, there are other approaches, such as ours,” stated BrainCo partner and senior vice president Nixie He.
During the event, the company conducted a live demonstration. A man with a bionic hand took the stage and showcased the device’s response to nerve impulses, moving his fingers solely by thought.
Company representatives claimed it is the world’s first prosthesis allowing independent control of each finger.
The participant then played a short piece on the piano.
“The sensors merely touch the skin and read the neural signals beneath it. Then the muscles contract to move the hand,” said He.
According to her, the non-invasive approach is safer, more readily accepted by patients, and reduces risks and costs.
A well-known player in the BCI field, Neuralink, employs an invasive method. The company inserts ultra-thin threads with electrodes at their ends into brain tissue. These read neuron activity related to the intention to perform an action. This approach offers higher accuracy, but the signal quality diminishes over time.
He mentioned that her company’s technology can be used to enhance concentration and improve sleep quality.
BrainCo was founded in the United States by Harvard University graduate Han Bicheng. He holds a master’s degree in law from Harvard Law School.
Last year, the firm established its Asia-Pacific headquarters and a research base in Hong Kong’s Cyberport.
Earlier in March, China’s regulator approved the country’s first neural implant for commercial use.